CBD Life Sciences CBDL Stock
0.0001 USD
{{ price }}
-50.000000%
{{change_pct}}%
SECTOR
Healthcare
COUNTRY
United States
Exchange
Other OTC
Market Cap
35.85K USD
LOW - HIGH [24H]
0.0000
-
0.0001 USD
VOLUME [24H]
2.22M USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD
CBD Life Sciences Price Chart
CBD Life Sciences CBDL Financial and Trading Overview
| CBD Life Sciences stock price | 0.0001 USD |
| Previous Close | 0.0001 USD |
| Open | 0.0001 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 1.0E-6 - 0.0001 USD |
| 52 Week Range | 1.0E-6 - 0.0002 USD |
| Volume | 4.67M USD |
| Avg. Volume | 9.09M USD |
| Market Cap | 358 USD |
| Beta (5Y Monthly) | 60.211266 |
| PE Ratio (TTM) | Infinity |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CBDL Valuation Measures
| Enterprise Value | 3.83M USD |
| Trailing P/E | Infinity |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.002590636 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 27.742 |
| Enterprise Value/EBITDA | N/A |
Trading Information
CBD Life Sciences Stock Price History
| Beta (5Y Monthly) | 60.211266 |
| 52-Week Change | -50.00000000000000000000000000000000% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.0002 USD |
| 52 Week Low | 1.0E-6 USD |
| 50-Day Moving Average | 9.7E-5 USD |
| 200-Day Moving Average | 0.00011825 USD |
CBDL Share Statistics
| Avg. Volume (3 month) | 9.09M USD |
| Avg. Daily Volume (10-Days) | 4.65M USD |
| Shares Outstanding | 3.59K |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:100 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | June 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -2329.37% |
| Gross Margin | 46.79% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 138.19K USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | 242.79% |
| Gross Profit (ttm) | 27.43K USD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -3218967 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 303.09K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 0 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -3396434 USD |
| Levered Free Cash Flow (ttm) | N/A |
Profile of CBD Life Sciences
| Country | United States |
| State | AZ |
| City | Scottsdale |
| Address | 10855 N 116th Street |
| ZIP | 85259 |
| Phone | 480 410 6780 |
| Website | https://lbcbioscienceinc.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 4 |
CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. The company is based in Scottsdale, Arizona.
Q&A For CBD Life Sciences Stock
What is a current CBDL stock price?
CBD Life Sciences CBDL stock price today per share is 0.0001 USD.
How to purchase CBD Life Sciences stock?
You can buy CBDL shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CBD Life Sciences?
The stock symbol or ticker of CBD Life Sciences is CBDL.
Which industry does the CBD Life Sciences company belong to?
The CBD Life Sciences industry is Drug Manufacturers-Specialty & Generic.
How many shares does CBD Life Sciences have in circulation?
The max supply of CBD Life Sciences shares is 358.5M.
What is CBD Life Sciences Price to Earnings Ratio (PE Ratio)?
CBD Life Sciences PE Ratio is now.
What was CBD Life Sciences earnings per share over the trailing 12 months (TTM)?
CBD Life Sciences EPS is 0 USD over the trailing 12 months.
Which sector does the CBD Life Sciences company belong to?
The CBD Life Sciences sector is Healthcare.